Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

NDAQ:NVCN - Post Discussion

Neovasc Inc. > R/S for TSX?
View:
Post by Dchan05 on May 19, 2018 3:57pm

R/S for TSX?

How does the reverse split affect TSX investors if the company is meeting the minimum requirements of the TSX? Is it all a matter of time where TSX will also R/S?
Comment by Barewood on May 21, 2018 7:28pm
Dchan05, I inboxed you with an explanation.
Comment by nretotrading on May 22, 2018 9:15am
Can you also ibox me re: TSX split? Thx
Comment by Barewood on May 22, 2018 9:43am
I did
Comment by Dchan05 on May 22, 2018 10:55am
Thanks man. Much appreciated!!
Comment by Barewood on May 22, 2018 11:49am
You're welcome!
Comment by bhavin0087 on May 23, 2018 10:59am
Please inbox me the same, thanks in advance
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities